Inhibrx
Biotechnology

Inhibrx: Funding & valuation

Inhibrx has $668.6M paid in by investors, lenders and donors.

Financials

Funding rounds, investors and revenue on record.

$668.6MTotal raised
$448kPublic grants2 public grants
Venture - Series UnknownLatest round
7Rounds and grants
Money by yearUSD, rounds and grants
2023$200M1 record
2020$15M1 record
2019$40M1 record
2018$413.6M2 records
2017$448k2 records
Sources: funding announcements, grant and company registers

Money

Inhibrx has $668.6M paid in by investors, lenders and donors.

$668.6MPaid in
StagePaidSignedAnnouncedSourceFiledAnnouncedPress
Money in
Equity raised
Aug 2023 · Venture round
$200MPaid
Equity raised
Apr 2020 · Venture round
$15MPaid
Equity raised
May 2019 · Venture round
$40MPaid
4 more records: amounts, dates and sources of every round, loan and commitmentProUnlockor this company alone for 30 days · 50 credits
Fund markswhat funds reporting to the SEC say their stakes are worth

Funds reporting to the SEC (2) valued their Inhibrx stock at $47k as of Jun 2026.

Price a share in fund marks, by quarter
Jun 2026median of 2 marks · sec.gov ↗$4.11
Mar 2026median of 2 marks · sec.gov ↗$4.11
Dec 2025median of 2 marks · sec.gov ↗$4.11
Sep 2025median of 2 marks · sec.gov ↗$4.11
Marks by fund: shares held, the price a share, the change since the last quarterPremiumUnlockor this company alone for 30 days · 50 credits
People cost

Inhibrx filed a median H-1B wage of $129k in 2025.

$129kMedian H-1B wage, 20252 casesSource ↗
$74k–$184kH-1B wage range2 positions
Median H-1B wage by role, 2025scale to $184k
Research Associate I · 1$74k
Senior Scientist, Analytical Development and Quality Control · 1$184k
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".